OCCURX
OccuRx, a Melbourne-based biopharmaceutical company, was established in 2014 with venture funding from the Medical Research Commercialisation Fund, Brandon Capital Partners and Uniseed. The Company’s primary focus is on the development of innovative therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis.
OCCURX
Social Links:
Industry:
Biopharma Biotechnology Medical Therapeutics
Founded:
2014-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.occurx.com
Total Employee:
11+
Status:
Active
Contact:
+61396570704
Email Addresses:
[email protected]
Total Funding:
5.19 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Global Site Tag Nginx
Similar Organizations
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Employees Featured
Founder
Investors List
Stoic VC
Stoic VC investment in Series A - OccuRx
Uniseed Ventures
Uniseed Ventures investment in Series A - OccuRx
Uniseed Ventures
Uniseed Ventures investment in Venture Round - OccuRx
Brandon Capital Partners
Brandon Capital Partners investment in Venture Round - OccuRx
Medical Research Commercialisation Fund (MRCF)
Medical Research Commercialisation Fund (MRCF) investment in Venture Round - OccuRx
Official Site Inspections
http://www.occurx.com Semrush global rank: 5.23 M Semrush visits lastest month: 1.56 K
- Host name: 170.64.249.143
- IP address: 170.64.249.143
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "OccuRx"
OccuRx - Crunchbase Company Profile & Funding
Company Type For Profit. Contact Email [email protected]. Phone Number +61396570704. OccuRx, a Melbourne-based biopharmaceutical company, was established in 2014 with …See details»
OccuRx Company Profile 2024: Valuation, Funding & Investors
OccuRx General Information Description. Developer of therapeutic strategies designed to aid in the treatment of disorders associated with retinal fibrosis. The company's strategies offer …See details»
OccuRx - Brandon Capital
OccuRx was established in 2014 with venture funding from Brandon BioCatalyst (formerly the Medical Research Commercialisation Fund/MRCF), Brandon Capital Partners and Uniseed. …See details»
OccuRx - Products, Competitors, Financials, Employees, …
OccuRx primarily serves the medical and healthcare industry. It was founded in 2014 and is based in Melbourne, Victoria. Headquarters Location. Level 9 278 Collins Street. Melbourne, …See details»
OccuRx - Funding, Financials, Valuation & Investors - Crunchbase
OccuRx is a biopharmaceutical company that focuses on the development of innovative therapeutic strategies. Search Crunchbase. Start Free Trial . Chrome Extension. ... How much …See details»
Occurx Company Profile - Office Locations, Competitors, Revenue …
OccuRx is a company developing therapies for the treatment of ocular inflammation and fibrosis. It leverages its proprietary small molecule drugs to address the unmet clinical need for more …See details»
OccuRx - VentureRadar
OccuRx has identified and validated a series of lead candidates against novel targets and established preclinical proof of concept to treat and prevent ocular fibrosis. The Company is …See details»
OccuRx – Brandon BioCatalyst
Brandon Biocatalyst is managed by Brandon Capital. Melbourne. Level 9, 31 Queen Street. Melbourne VIC 3000. Phone +61 3 9657 0700. Email: [email protected]. Sydney. …See details»
OccuRx launched with up to AU$6.5 M in funding | Fierce Pharma
May 18, 2015 About OccuRx . OccuRx, a Melbourne-based biopharmaceutical company, was established in 2014 with venture funding from the Medical Research Commercialisation Fund, …See details»
OccuRx represented at Biotechnology Innovation Organisation …
May 6, 2023 Melbourne, Australia, 05 June 2023: OccuRx, a biotechnology company focused on improving lives by developing innovative precision treatments for inflammatory and fibrotic …See details»
OccuRx - Contacts, Employees, Board Members, Advisors
Organization. OccuRx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Contacts 1. ... OccuRx …See details»
$16m cash injection to progress first-in-class therapy for …
September 5, 2022. Australian start-up OccuRx accelerates therapy development for diseases associated with inflammation and fibrosis – the cause of 45% of all deaths globally 1. …See details»
Biotech startup OccuRx raises $16 million for kidney disease trial
Sep 9, 2022 Biotech startup OccuRx has raised $16 million to fund clinical phase studies for its oral therapy to treat chronic kidney disease (CKD), a leading cause of death. The round was …See details»
OccuRx joins 41st Annual J.P. Morgan Healthcare Conference, San ...
Melbourne, Australia, 09 January 2023: OccuRx, a biotechnology company focused on improving lives by developing innovative precision treatments for inflammatory and fibrotic diseases, are …See details»
OccuRx joins 39th Annual J.P. Morgan Healthcare Conference …
Melbourne, Australia, 09 January 2021: OccuRx, a biotechnology company focused on improving lives by developing innovative precision treatments for inflammatory and fibrotic diseases, are …See details»
OccuRx - Crunchbase
OccuRx is a biopharmaceutical company that focuses on the development of innovative therapeutic strategies. Search Crunchbase ... Products. Resources. Pricing. Resources. Log …See details»
OccuRx - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Jul 15, 2024 OccuRx uses 9 technology products and services including HTML5, Google Fonts, and Apache Server, according to G2 Stack. OccuRx is actively using 4 technologies for its …See details»
OccuRx team to meet with biotech industry leaders during …
Oct 20, 2022 OccuRx is seeking to combine these innovative therapeutics with biomarkers and genetic analysis to identify those patients most likely to benefit from treatment. The company’s …See details»
OccuRx raises awareness of the importance of World Diabetes Day
Nov 13, 2022 Melbourne, Australia, 14 November 2022: OccuRx, a biotechnology company focused on improving lives by developing innovative precision treatments for inflammatory and …See details»
OccuRx presents new research at ARVO conference in Vancouver
Melbourne, Australia, 28 April 2019: OccuRx, a biotechnology company focused on improving lives by developing innovative precision treatments for inflammatory and fibrotic diseases, is …See details»